Literature DB >> 34411872

The effects of rational emotive behavior therapy for depressive symptoms in adults with congenital heart disease.

Ju Ryoung Moon1, June Huh2, Jinyoung Song3, I-Seok Kang3, Seung Woo Park4, Sung-A Chang4, Ji-Hyuk Yang5, Tae-Gook Jun5, Jong-Sook Han6.   

Abstract

BACKGROUND: Over 30% of adults with congenital heart disease (CHD) experience depression.
OBJECTIVES: To evaluate the effectiveness of Rational Emotive Behavior Therapy (REBT) in reducing depressive symptoms in adults with CHD.
METHODS: Forty-two adults with CHD were recruited from an outpatient clinic and randomized to a study group (n = 21), which comprised 8-weekly group-based counseling sessions, or a control group (n = 21), which received usual care. REBT effectiveness was examined using the Hamilton Depression Rating Scale, Beck Depression Inventory, Shorten General Attitude and Belief Scale, and salivary cortisol levels before therapy, after the last session, and at follow-up 4 weeks later.
RESULTS: Average participant ages were 30.1 ± 7.58 and 33.3 ± 7.1 years in study and control groups, respectively; 52.4% of participants in each group were female. After REBT, depression (p < 0.001), irrational beliefs (p < 0.001), and salivary cortisol levels (p = 0.006) were significantly lower in the study group than in the control group. Effects of REBT in the study group remained consistent at the 4-week follow-up.
CONCLUSION: REBT may be effective in reducing depression in adults with CHD.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Congenital heart disease; Depressive symptoms; Rational emotive behavior therapy

Mesh:

Year:  2021        PMID: 34411872     DOI: 10.1016/j.hrtlng.2021.07.011

Source DB:  PubMed          Journal:  Heart Lung        ISSN: 0147-9563            Impact factor:   2.210


  1 in total

1.  Intervention for depression among undergraduate religious education students: A randomized controlled trial.

Authors:  Chiedu Eseadi; Leonard Chidi Ilechukwu; Vera Victor-Aigbodion; Abatihun Alehegn Sewagegn; Amos Nnaemeka Amedu
Journal:  Medicine (Baltimore)       Date:  2022-10-14       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.